Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.3085 USD
−21.67 M USD
68.00 K USD
48.88 M
About Eterna Therapeutics Inc.
Sector
CEO
Sanjeev Luther
Headquarters
Cambridge
Website
Founded
1984
FIGI
BBG000CX5677
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ERNA is 0.2490 USD — it has increased by 1.47% in the past 24 hours. Watch Eterna Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eterna Therapeutics Inc. stocks are traded under the ticker ERNA.
ERNA stock has fallen by −11.07% compared to the previous week, the month change is a −57.00% fall, over the last year Eterna Therapeutics Inc. has showed a −84.82% decrease.
ERNA reached its all-time high on Jun 23, 1993 with the price of 23,000.0000 USD, and its all-time low was 0.2212 USD and was reached on Dec 19, 2024. View more price dynamics on ERNA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ERNA stock is 5.74% volatile and has beta coefficient of 1.03. Track Eterna Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Eterna Therapeutics Inc. there?
Today Eterna Therapeutics Inc. has the market capitalization of 12.79 M, it has decreased by −6.26% over the last week.
Yes, you can track Eterna Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Eterna Therapeutics Inc. is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
ERNA net income for the last quarter is −26.60 M USD, while the quarter before that showed −5.53 M USD of net income which accounts for −381.17% change. Track more Eterna Therapeutics Inc. financial stats to get the full picture.
No, ERNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 8.00 employees. See our rating of the largest employees — is Eterna Therapeutics Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eterna Therapeutics Inc. EBITDA is −18.27 M USD, and current EBITDA margin is −28.75 K%. See more stats in Eterna Therapeutics Inc. financial statements.
Like other stocks, ERNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eterna Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eterna Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eterna Therapeutics Inc. stock shows the sell signal. See more of Eterna Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.